Tag Archives: Gates Foundation

In a recent Bloomberg interview, Microsoft founder and noted philanthropist Bill Gates debunked much of the recent criticism of the biopharmaceutical industry and the drug pricing system in the United States, stating: “The current system is better than most other systems one can imagine … The drug companies are turning out miracles, and we need their R&D budgets to stay strong. They need to see the opportunity.” Gates also praised the innovations that are coming Read More >

Today, Trevor Mundel from the Bill & Melinda Gates Foundation discussed the untapped potential of biotech companies to help develop new and better drugs, vaccines, diagnostics, and delivery systems for global health solutions at the 2014 BIO International Convention. This is important because 90 percent of the global infectious disease burden is borne by those who live in developing countries, yet the foundation believes that little attention is paid to health solutions to address these Read More >

Join us for BIO’s Intellectual Property Counsels Committee Meeting in Seattle April 13-15. You can find the session topics below. Whose Rights Are They, Anyway? Implications from and a Discussion on Stanford v. Roche The pending Supreme Court review of Stanford v. Roche has brought out multiple perspectives on the disposition of ownership rights in federally funded inventions under Bayh-Dole. This session will explore the different interpretations of the Act’s provisions, and their practical implications Read More >